novaliq.com Report : Visit Site


  • Server:Apache...
    X-Powered-By:PHP/7.2.6

    The main IP address: 217.160.0.203,Your server Germany,Karlsruhe ISP:1&1 Internet AG  TLD:com CountryCode:DE

    The description :skip to content novaliq gmbh transforming ocular therapeutics about novaliq our dream team management team supervisory board scientific advisory board partners investor relations novaliq inc. eyesol®-...

    This report updates in 15-Jul-2018

Created Date:2007-05-03
Changed Date:2018-05-04

Technical data of the novaliq.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host novaliq.com. Currently, hosted in Germany and its service provider is 1&1 Internet AG .

Latitude: 49.004718780518
Longitude: 8.3858299255371
Country: Germany (DE)
City: Karlsruhe
Region: Baden-Wurttemberg
ISP: 1&1 Internet AG
    drugdevelopment-technology.com 

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

X-Powered-By:PHP/7.2.6
Transfer-Encoding:chunked
Set-Cookie:PHPSESSID=f4b740ca9c941b8628b1ecb39ad4f08e; path=/
Expires:Thu, 19 Nov 1981 08:52:00 GMT
X-TEC-API-VERSION:v1
Keep-Alive:timeout=15
Server:Apache
Connection:keep-alive
X-TEC-API-ORIGIN:https://www.novaliq.com
Link:; rel="https://api.w.org/", ; rel=shortlink
X-UA-Compatible:IE=EmulateIE10
Pragma:no-cache
Cache-Control:no-store, no-cache, must-revalidate
Date:Sun, 15 Jul 2018 07:08:17 GMT
Content-Type:text/html; charset=UTF-8
X-TEC-API-ROOT:https://www.novaliq.com/wp-json/tribe/events/v1/
Content-Encoding:gzip

DNS

soa:ns1035.ui-dns.org. hostmaster.kundenserver.de. 2016110401 28800 7200 604800 600
ns:ns1035.ui-dns.com.
ns1035.ui-dns.biz.
ns1035.ui-dns.org.
ns1035.ui-dns.de.
ipv4:IP:217.160.0.203
ASN:8560
OWNER:ONEANDONE-AS Brauerstrasse 48, DE
Country:DE
ipv6:2001:8d8:100f:f000::2ea//8560//ONEANDONE-AS Brauerstrasse 48, DE//DE
txt:"v=spf1 mx a:mx01.rexx-systems.de ~all"
mx:MX preference = 1, mail exchanger = mail.novaliq.com.
MX preference = 10, mail exchanger = mail1.novaliq.com.

HtmlToText

skip to content novaliq gmbh transforming ocular therapeutics about novaliq our dream team management team supervisory board scientific advisory board partners investor relations novaliq inc. eyesol®-technology products dry eye disease novatears® cyclasol® novatears®+omega-3 news press releases publications and poster events contact careers media about novaliq our dream team management team supervisory board scientific advisory board partners investor relations novaliq inc. eyesol®-technology products dry eye disease novatears® cyclasol® novatears®+omega-3 news press releases publications and poster events contact careers media | transformative drug delivery technology for the front and the back of the eye novaliq gmbh, founded in 2007, is a specialty pharmaceutical company focused on the development of innovative water-free ophthalmics and located in the heidelberg technology park, germany. our mission is to transform active pharmaceutical ingredients (apis) into highly effective ocular therapeutics for both the front and the back of the eye. novatears ® , a first-in-class, water-free product with a novel mode of action for treatment of evaporative dry eye is registered and marketed in europe. the most advanced rx development is cyclasol ® for the treatment of moderate to severe dry eye disease. recent reported phase 2 data confirmed that cyclasol ® has demonstrated a superior outcome and an earlier onset of action when compared head to head vs. restasis™. all product developments are based on novaliq’s proprietary drug delivery technology called eyesol ® which enhances the topical bio-availability, stability and safety of traditionally unstable apis improving the delivery, efficacy and convenience of treatments for ocular surface diseases, including dry eye, through preservative free and multi dose formulations. set your eyes on the future - contact us! schedule your appointment now! contact us today! latest news at octane’s ophthalmology technology summit, bernhard günther discusses the company’s progress in bringing eye products into the us market 11. july 2018 novaliq’s novatears® treatment for evaporative dry eye disease is now available across australia and new zealand 28. june 2018 novaliq at ophthalmology technology summit 2018 26. june 2018 study finds novatears increases tear film, lipid layer thickness. 5. june 2018 study finds novatears increases tear film, lipid layer thickness 4. june 2018 study finds novatears can increase tear film thickness 7. may 2018 novaliq to present scientific and clinical research during the 2018 association for research in vision and ophthalmology meeting in honolulu, hi 25. april 2018 novaliq seeks entry into us dry eye market – interview with bernhard günther @ascrs 16. april 2018 what opportunities does the dry eye challenge hold for the ophthalmology industry? 19. march 2018 novaliq establishes u.s. subsidiary in cambridge, massachusetts to strengthen its presence in the growing u.s. eye care market 8. january 2018 novaliq announces first patient enrolled in its seecase phase 2 trial of nov03 for the treatment of dry eye disease 8. january 2018 novaliq’s novatears®+omega-3 approved in europe for the enhanced treatment of evaporative dry eye disease 6. december 2017 novaliq announces first patient randomized in its essence phase 2b/3 trial of cyclasol® for the treatment of the signs and symptoms of dry eye disease 9. november 2017 novaliq’s novatears® treatment for evaporative dry eye disease launches in new zealand and receives registrational approval in australia 30. october 2017 german ophthalmological society honors uta gehlsen with prestigious scientific award for her research on the use of semifluorinated alkanes in dry eye treatment 6. october 2017 novaliq strengthens executive management team with the appointment of gabriela burian, md, mph, as consulting chief medical officer 11. july 2017 novaliq conducts a first-in-class ocular neuropathic pain and anti-inflammatory cannabinoid drug development program in collaboration with the university of cologne, germany 8. may 2017 novaliq gmbh announces licensing agreement with aft pharmaceuticals for the distribution of novatears® 21. march 2017 novaliq announces positive topline results of phase 2 clinical trial evaluating cyclasol® in adults with moderate to severe dry eye disease 5. january 2017 novaliq strengthens executive management team by appointing christian roesky (phd, as chief executive officer) 6. october 2016 novaliq names renown international experts to inaugural scientific advisory board 8. september 2016 novaliq announces last patient enrolled in phase 2 clinical trial of cyclasol® for the treatment of moderate to severe dry eye disease 5. may 2016 novaliq begins phase 2 clinical trial of cyclasol® for the treatment of moderate to severe dry eye disease 16. february 2016 novatears® significantly stabilizes the tear film and relieves dry eye symtoms in patients with evaporative dry eye disease 16. december 2015 novaliq gmbh appoints friedrich von bohlen, phd, as chairman and gerald cagle, phd, as new member of novaliq´s supervisory board 8. december 2015 ursapharm gmbh and novaliq gmbh announce european partnership agreementannounce european partnership agreement 1. october 2015 novaliq gmbh strengthens executive management team by appointing oliver schlüter, phd as managing director and cfo, and hartmut voss, phd as cbo 10. september 2015 products novatears® cyclasol® novatears®+omega-3 partnering ursapharm aft pharmaceuticals ltd academic partners investor relations get in contact novaliq gmbh im neuenheimer feld 515 69120 heidelberg germany +49 6221 50259-0 [email protected] legal links data privacy cookie policy imprint data privacy | cookie-policy | imprint follow us on: linkedin | youtube | twitter | made with in heidelberg. go to top novaliq uses cookies which are necessary for the proper functioning of its website. novaliq may also use cookies to remember session management, to collect statistics, and to optimize site functionality. click agree and proceed to accept cookies and go directly to the site. find out more. agree and proceed

URL analysis for novaliq.com


https://www.novaliq.com/2017/03/21/novaliq-gmbh-announces-licensing-agreement-with-aft-pharmaceuticals-for-the-distribution-of-novatears/
https://www.novaliq.com/2015/10/01/ursapharm-gmbh-and-novaliq-gmbh-announce-european-partnership-agreementannounce-european-partnership-agreement/
https://www.novaliq.com/2016/10/06/novaliq-strengthens-executive-management-appointing-christian-roesky/
https://www.novaliq.com/2016/10/06/
https://www.novaliq.com/2017/10/30/novaliqs-novatears-treatment-for-evaporative-dry-eye-disease-launches-in-new-zealand-and-receives-registrational-approval-in-australia/
https://www.novaliq.com/2018/06/28/novaliqs-novatears-treatment-for-evaporative-dry-eye-disease-is-now-available-across-australia-and-new-zealand/
https://www.novaliq.com/2018/04/16/
https://www.novaliq.com/contact/careers/
https://www.novaliq.com/2016/05/05/
https://www.novaliq.com/about-novaliq/partners/
https://www.novaliq.com/2018/03/19/ceo-roesky-sees-dry-eye-challenges-as-opportunities-for-novaliq/
https://www.novaliq.com/de/
https://www.novaliq.com/2015/12/08/novaliq-gmbh-appoints-friedrich-von-bohlen-phd-as-chairman-and-gerald-cagle-phd-as-new-member-of-novaliqs-supervisory-board/
https://www.novaliq.com/2016/05/05/novaliq-announces-last-patient-enrolled-in-phase-2-clinical-trial-of-cyclasol-for-the-treatment-of-moderate-to-severe-dry-eye-disease/
https://www.novaliq.com/cookie-policy/

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: NOVALIQ.COM
Registry Domain ID: 955765465_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2018-05-04T07:22:26Z
Creation Date: 2007-05-03T09:10:07Z
Registry Expiry Date: 2019-05-03T09:10:07Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1035.UI-DNS.BIZ
Name Server: NS1035.UI-DNS.COM
Name Server: NS1035.UI-DNS.DE
Name Server: NS1035.UI-DNS.ORG
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-07-15T07:08:08Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 1&1 Internet SE

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =novaliq.com

  PORT 43

  TYPE domain

DOMAIN

  NAME novaliq.com

  CHANGED 2018-05-04

  CREATED 2007-05-03

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS1035.UI-DNS.BIZ 217.160.81.35

  NS1035.UI-DNS.COM 217.160.82.35

  NS1035.UI-DNS.DE 217.160.80.35

  NS1035.UI-DNS.ORG 217.160.83.35

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.unovaliq.com
  • www.7novaliq.com
  • www.hnovaliq.com
  • www.knovaliq.com
  • www.jnovaliq.com
  • www.inovaliq.com
  • www.8novaliq.com
  • www.ynovaliq.com
  • www.novaliqebc.com
  • www.novaliqebc.com
  • www.novaliq3bc.com
  • www.novaliqwbc.com
  • www.novaliqsbc.com
  • www.novaliq#bc.com
  • www.novaliqdbc.com
  • www.novaliqfbc.com
  • www.novaliq&bc.com
  • www.novaliqrbc.com
  • www.urlw4ebc.com
  • www.novaliq4bc.com
  • www.novaliqc.com
  • www.novaliqbc.com
  • www.novaliqvc.com
  • www.novaliqvbc.com
  • www.novaliqvc.com
  • www.novaliq c.com
  • www.novaliq bc.com
  • www.novaliq c.com
  • www.novaliqgc.com
  • www.novaliqgbc.com
  • www.novaliqgc.com
  • www.novaliqjc.com
  • www.novaliqjbc.com
  • www.novaliqjc.com
  • www.novaliqnc.com
  • www.novaliqnbc.com
  • www.novaliqnc.com
  • www.novaliqhc.com
  • www.novaliqhbc.com
  • www.novaliqhc.com
  • www.novaliq.com
  • www.novaliqc.com
  • www.novaliqx.com
  • www.novaliqxc.com
  • www.novaliqx.com
  • www.novaliqf.com
  • www.novaliqfc.com
  • www.novaliqf.com
  • www.novaliqv.com
  • www.novaliqvc.com
  • www.novaliqv.com
  • www.novaliqd.com
  • www.novaliqdc.com
  • www.novaliqd.com
  • www.novaliqcb.com
  • www.novaliqcom
  • www.novaliq..com
  • www.novaliq/com
  • www.novaliq/.com
  • www.novaliq./com
  • www.novaliqncom
  • www.novaliqn.com
  • www.novaliq.ncom
  • www.novaliq;com
  • www.novaliq;.com
  • www.novaliq.;com
  • www.novaliqlcom
  • www.novaliql.com
  • www.novaliq.lcom
  • www.novaliq com
  • www.novaliq .com
  • www.novaliq. com
  • www.novaliq,com
  • www.novaliq,.com
  • www.novaliq.,com
  • www.novaliqmcom
  • www.novaliqm.com
  • www.novaliq.mcom
  • www.novaliq.ccom
  • www.novaliq.om
  • www.novaliq.ccom
  • www.novaliq.xom
  • www.novaliq.xcom
  • www.novaliq.cxom
  • www.novaliq.fom
  • www.novaliq.fcom
  • www.novaliq.cfom
  • www.novaliq.vom
  • www.novaliq.vcom
  • www.novaliq.cvom
  • www.novaliq.dom
  • www.novaliq.dcom
  • www.novaliq.cdom
  • www.novaliqc.om
  • www.novaliq.cm
  • www.novaliq.coom
  • www.novaliq.cpm
  • www.novaliq.cpom
  • www.novaliq.copm
  • www.novaliq.cim
  • www.novaliq.ciom
  • www.novaliq.coim
  • www.novaliq.ckm
  • www.novaliq.ckom
  • www.novaliq.cokm
  • www.novaliq.clm
  • www.novaliq.clom
  • www.novaliq.colm
  • www.novaliq.c0m
  • www.novaliq.c0om
  • www.novaliq.co0m
  • www.novaliq.c:m
  • www.novaliq.c:om
  • www.novaliq.co:m
  • www.novaliq.c9m
  • www.novaliq.c9om
  • www.novaliq.co9m
  • www.novaliq.ocm
  • www.novaliq.co
  • novaliq.comm
  • www.novaliq.con
  • www.novaliq.conm
  • novaliq.comn
  • www.novaliq.col
  • www.novaliq.colm
  • novaliq.coml
  • www.novaliq.co
  • www.novaliq.co m
  • novaliq.com
  • www.novaliq.cok
  • www.novaliq.cokm
  • novaliq.comk
  • www.novaliq.co,
  • www.novaliq.co,m
  • novaliq.com,
  • www.novaliq.coj
  • www.novaliq.cojm
  • novaliq.comj
  • www.novaliq.cmo
Show All Mistakes Hide All Mistakes